ORB-0004

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameORB-0004

Drug Alias NameORB-0004

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein-tyrosine kinases inhibitors

TargetsProtein-tyrosine kinases

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOriBase Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesOriBase Pharma

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A